Currently browsing "Corrective and Preventive Action"

How can pharmaceutical manufacturers transform quality management challenges into innovation and market leadership opportunities? Corrective and Preventive Action (CAPA) records are essential in this process, providing critical insights into quality lapses and operational inefficiencies. Companies can proactively enhance their operations by analyzing and utilizing CAPA data, ensuring compliance with rigorous standards while driving significant product […]

Continue reading